Abstract
Qualitative differences in the MHC class II antigen processing and presentation pathway may be instrumental in shaping the CD4+ T cell response directed against tumour cells. Efficient loading of many MHC class II alleles with peptides requires the assistance of H2-M, a heterodimeric MHC class II-like molecule. In contrast to the HLA-DM region in humans, the β-chain locus is duplicated in mouse, with the H2-Mb1 (Mb1β-chain distal to H2-Mb2 (Mb2) and the H2-Ma (Ma) α-chain gene). Here, we show that murine MHC class II and H2-M genes are coordinately regulated in murine tumour cell lines by T helper cell 1 (IFN-γ) and T helper cell 2 (IL-4 or IL-10) cytokines in the presence of the MHC class II-specific transactivator CIITA as determined by mRNA expression and Western blot analysis. Furthermore, Mαβ1 and Mαβ2 heterodimers are differentially expressed in murine tumour cell lines of different histology. Both H2-M isoforms promote equally processing and presentation of native protein antigens to H2-Ad- and H2-Ed-restricted CD4+ T cells. Murine tumour cell lines could be divided into three groups: constitutive MHC class II and CIITA expression; inducible MHC class II and CIITA expression upon IFN-γ-treatment; and lack of constitutive and IFN-γ-inducible MHC class II and CIITA expression. These differences may impact on CD4+ T cell recognition of cancer cells in murine tumour models. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Agarwal S and Rao A (1998) Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 9: 765–775
Armstrong TD, Clements VK, Martin BK, Ting JPY and Ostrand-Rosenberg S (1997) Major histocompatibility complex class II-transfected tumour cells present endogenous antigen and are potent inducers of tumour-specific immunity. Proc Natl Acad Sci USA 94: 6886–6891
Bakke O and Dobberstein B (1990) MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 63: 707–716
Becker Andre M and Hahlbrock K (1989) Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY). Nucleic Acids Res 17: 9437–9446
Bouaboula M, Legoux P, Pessegue B, Delpech B, Dumont X, Piechaczyk M, Casellas P and Shire D (1992) Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control. J Biol Chem 267: 21830–21838
Chang CH, Guerder S, Hong SC, van Ewijk W and Flavell RA (1996) Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4: 167–178
Cho SG, Attaya M and Monaco JJ (1991) New class II-like genes in the murine MHC. Nature 353: 573–576
Cresswell P (1996) Invariant chain structure and MHC class II function. Cell 84: 505–507
Cresswell P (1998) Proteases, processing, and thymic selection. Science 280: 394–395
Denzin LK, Hammond C and Cresswell P (1996) HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J Exp Med 184: 2153–2165
Denzin LK, Robbins NF, Carboy Newcomb C and Cresswell P (1994) Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells. Immunity 1: 595–606
Fremont DH, Crawford F, Marrack P, Hendrickson WA and Kappler J (1998) Crystal structure of mouse H2-M. Immunity 9: 385–393
Haberhausen G, Pinsl J, Kuhn CC and Markert Hahn C (1998) Comparative study of different standardization concepts in quantitative competitive reverse transcription-PCR assays. J Clin Microbiol 36: 628–633
Hardison R (1998) Hemoglobins from bacteria to man: evolution of different patterns of gene expression. J Exp Biol 201: 1099–1117
Hsieh CL (1997) Stability of patch methylation and its impact in regions of transcriptional initiation and elongation. Mol Cell Biol 17: 5897–5904
Kelly AP, Monaco JJ, Cho SG and Trowsdale J (1991) A new human HLA class II-related locus, DM. Nature 353: 571–573
Kerkmann-Tucek A, Banat GA, Cochlovius B and Zoller M (1998) Antigen loss variants of a murine renal cell carcinoma: implications for tumour vaccination. Int J Cancer 77: 114–122
Kirberg J, Baron A, Jakob S, Rolink A, Karjalainen K and von Boehmer H (1994) Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor. J Exp Med 180: 25–34
Kleijmeer MJ, Morkowski S, Griffith JM, Rudensky AY and Geuze HJ (1997) Major histocompatibility complex class II compartments in human and mouse B lymphoblasts represent conventional endocytic compartments. J Cell Biol 139: 639–649
Lingnau K, Hoehn P, Kerdine S, Koelsch S, Neudoerfl C, Palm N, Ruede E and Schmitt E (1998) IL-4 in combination with TGF-beta favors an alternative pathway of Th1 development independent of IL-12. J Immunol 161: 4709–4718
Mach B, Steimle V, Martinez Soria E and Reith W (1996) Regulation of MHC class II genes: lessons from a disease. Annu Rev Immunol 14: 301–331
Miyazaki T, Wolf P, Tourne S, Waltzinger C, Dierich A, Barois N, Ploegh H, Benoist C and Mathis D (1996) Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell 84: 531–541
Mongini C, Sanchez Lockart M, Waldner CI, Alvarez EM, Gravisaco MJ, Roig MI and Hajos SE (1996) Enhancement of anti-tumour immunity in syngeneic mice after MHC class II gene transfection. Br J Cancer 74: 258–263
Muhlethaler Mottet A, Otten LA, Steimle V and Mach B (1997) Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J 16: 2851–2860
Murphy KM, Heimberger AB and Loh DY (1990) Induction by antigen of intrathymic apoptosis of CD4+ CD8+ TCRlo thymocytes in vivo. Science 250: 1720–1723
Ossendorp F, Mengede E, Camps M, Filius R and Melief CJ (1998) Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumours. J Exp Med 187: 693–702
Pardoll DM and Topalian SL (1998) The role of CD4+ T cell responses in antitumour immunity. Curr Opin Immunol 10: 588–594
Peleraux A, Karlsson L, Chambers J and Peterson PA (1996) Genomic organization of a mouse MHC class II region including the H2-M and Lmp2 loci. Immunogenetics 43: 204–214
Riberdy JM, Newcomb JR, Surman MJ, Barbosa JA and Cresswell P (1992) HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature 360: 474–477
Sanderson F, Thomas C, Neefjes J and Trowsdale J (1996) Association between HLA-DM and HLA-DR in vivo. Immunity 4: 87–96
Sartoris S, Valle MT, Barbaro AL, Tosi G, Cestari T, D’Agostino A, Megiovanni AM, Manca F and Accolla RS (1998) HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity. J Immunol 161: 814–820
Scholl T, Mahanta SK and Strominger JL (1997) Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. Proc Natl Acad Sci USA 94: 6330–6334
Sette A, Southwood S, Miller J and Appella E (1995) Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regualted by allelic polymorphism in class II. J Exp Med 181: 677–683
Urban RG, Chicz RM and Strominger JL (1994) Selective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pH. J Exp Med 180: 751–755
Van Ham SM, Gruneberg U, Malcherek G, Broker I, Melms A and Trowlsdale J (1996) Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs. J Exp Med 184: 2019–2024
Walter W, Loos M and Maeurer MJ (1996) H2-M polymorphism in mice susceptible to collagen-induced arthritis involves the peptide binding groove. Immunogenetics 44: 19–26
Walter W, Scheuer C, Loos M, Reichert TE and Maeurer MJ H2-Mβ1 or H2-Mβ2 heterodimers equally promote CLIP removal in 1-Aq molecules from autoimmune-prone DBA/1 mice. J Biol Chem, (in press)
Westerheide SD, Louis Plence P, Ping D, He XF and Boss JM (1997) HLA-DMA and HLA-DMB gene expression functions through the conserved S-X-Y region. J Immunol 158: 4812–4821
Wolf PR and Ploegh HL (1995) How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Annu Rev Cell Dev Biol 11: 267–306
Wolf PR, Tourne S, Miyazaki T, Benoist C, Mathis D and Ploegh HL (1998) The phenotype of H-2M-deficient mice is dependent on the MHC class II molecules expressed. Eur J Immunol 28: 2605–2618
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Walter, W., Lingnau, K., Schmitt, E. et al. MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?. Br J Cancer 83, 1192–1201 (2000). https://doi.org/10.1054/bjoc.2000.1415
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1415
Keywords
This article is cited by
-
Type II alveolar cell MHCII improves respiratory viral disease outcomes while exhibiting limited antigen presentation
Nature Communications (2021)
-
Microarray analysis reveals potential mechanisms of BRMS1-mediated metastasis suppression
Clinical & Experimental Metastasis (2007)
-
CD8+ T cells, NK cells and IFN-γ are important for control of tumor with downregulated MHC class I expression by DNA vaccination
Gene Therapy (2003)